Investigation of the Effects of Early Skin-to-Skin Contact on Mother and Baby in Cesarean Births

NCT ID: NCT07111949

Last Updated: 2026-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-19

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The rate of cesarean birth continues to increase in the world and in our country. As with all surgeries, the risks of cesarean birth include the possibility of bleeding and infection, prolonged recovery time after birth, delays in initiating breastfeeding and skin-to-skin contact (SSC), and increased likelihood of complications in future pregnancies.

While many hospitals apply SSC after normal births, it is known that the number of hospitals that apply SSC in the operating room after cesarean birth is very few. Factors that prevent the initiation of SSC after cesarean birth include the effect of the current operating room culture, the physiological evaluation process of the baby after birth, the presence of procedures such as measuring body weight, aspiration, and Apgar score evaluation.

Since the mother and baby are separated after cesarean birth, the mother's initiation of breastfeeding in the first hour of life may be delayed, and the duration of exclusive breastfeeding may be shortened. The 90-minute uninterrupted skin-to-skin contact during which the baby is dried and placed directly on the mother's bare chest after birth maximizes the chance that babies are physically ready to breastfeed.

Although there are studies showing the benefits of SSC application in the operating room such as breastfeeding rates, maintaining the body temperature of the newborn, reducing maternal stress levels, and increasing oxytocin levels, a limited number of studies have been reached in the literature using SSC application guidelines developed to ensure the sustainability of SSC application in the operating room, post-op care unit, and obstetrics clinic. The first contribution of this planned study to the literature will be to standardize SSC application with SSC checklists prepared for use in the cesarean operation room, post-op care unit, and obstetrics ward based on SSC application guidelines. As a second contribution, considering the conditions of the health institution where the study will be conducted, the effects of starting SSC as early as possible and applying it in the cesarean operation room, post-op care unit, and obstetrics ward on the stress level of newborns, sucking success, and pain and salivary cortisol (stress) levels of mothers will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main purpose of the proposed study is to evaluate the effect of SSC initiated in different units of the hospital after cesarean delivery with spinal anesthesia on the stress level of newborns, sucking success, pain and salivary cortisol (stress) levels of mothers and physiological parameters of mothers and babies.

The secondary purpose of the study is to evaluate the satisfaction levels of mothers regarding the SSC application initiated in different units of the hospital after cesarean delivery.

Hypotheses of the Study H1: Early initiated SSC is more effective than late initiated SSC in reducing the pain level of mothers after cesarean deliveries.

H2: Early initiated SSC is more effective than late initiated SSC in reducing the salivary cortisol level of mothers after cesarean deliveries.

H3: Early initiated SSC is more effective than late initiated SSC in reducing the stress level of newborns after cesarean deliveries.

H4: Early initiated SSC is more effective than late initiated SSC on the sucking success of newborns after cesarean deliveries.

H5: Early initiation of SSC is more effective than late initiation of SSC in increasing the satisfaction level of mothers after cesarean births.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin-to-skin Contact

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

In the study, if the condition of mothers and newborns is stable immediately after the cesarean section in group 1 (SSC1), SSC will be applied as continuously as possible in the cesarean operation room, post-op care unit and ward room.

In group 2 (SSC2), if the condition of mothers and newborns is stable after the cesarean section, SSC will be started in the post-op care unit and SSC will be continued in the ward room after the mother and baby are transferred to the maternity ward.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SSC Group 1 (Operation room)

Skin-to-skin contact (SSC) will be initiated in the operation room, will continue in the post-op care room, while SSC continues, the mother and baby will be transferred to the ward room, and SSC will be continued in the ward room.

Group Type ACTIVE_COMPARATOR

SSC Group 1 (Operation room)

Intervention Type OTHER

Salivary cortisol sampling from mothers, pain assessment (VAS), and measurement of physiological findings will be done at the following 3 measurement times. (1)Before transfer to the operating room (OR) (2)1 hour (h) after admission to the post-op room (PR) (3)at least 1 h after admission to the maternity ward (MW) The stress levels of the newborns will be assessed using the "Neonatal Stress Scale" at the following 4 measurement times, the heart rate and O2 saturation will be measured and recorded.

1. At least 5 min after the initiation of SSC in the OR
2. During the Hep-B vaccination in the PR
3. At least 30 min after SSC after admission to the MW
4. At least 24 h after birth in the MW, at least 30 min after SSC. The success of the newborn sucking will be assessed using the LATCH at the following 3 measurement times.

(1) At least 5 min after the initiation of SSC in the OR (2)At least 1 h after admission to the MW, during SSC (3)At least 24 h after birth in the MW during SSC.

SSC Group 2 (Post-operation room)

Skin-to-skin contact (SSC) will be initiated in the post-operative care unit, SSC will not be uninterrupted, SSC will be continued in the ward room.

Group Type ACTIVE_COMPARATOR

SSC Group 2 (Post-operation room)

Intervention Type OTHER

SC sampling from mothers, pain assessment (VAS), and measurement of physiological findings will be done at the following 3 measurement times. (1)Before transfer to the OR (2)1 hour (h) after admission to the PR (3)At least 1 h after admission to the MW.

The stress levels of newborns will be assessed using the "Neonatal Stress Scale" at the following 4 measurement times, and heart rate and oxygen saturation will be measured and recorded.

(1)At least 5 min after birth under radiant heater in the baby care room (BCR) (2)At least 10 min after being taken to the BCR during Hep-B vaccination under radiant heater (3)At least 5 min after being admitted to the maternity ward after SSC (4)5 min after being held in the mother's arms Newborn sucking success will be assessed using LATCH at the following 3 measurement times.

(1)At least 5 min after starting SSC in the post-op care unit (2)During SSC after being admitted to the MW (3)At least 24 h after being held in the mother's arms in the MW.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SSC Group 1 (Operation room)

Salivary cortisol sampling from mothers, pain assessment (VAS), and measurement of physiological findings will be done at the following 3 measurement times. (1)Before transfer to the operating room (OR) (2)1 hour (h) after admission to the post-op room (PR) (3)at least 1 h after admission to the maternity ward (MW) The stress levels of the newborns will be assessed using the "Neonatal Stress Scale" at the following 4 measurement times, the heart rate and O2 saturation will be measured and recorded.

1. At least 5 min after the initiation of SSC in the OR
2. During the Hep-B vaccination in the PR
3. At least 30 min after SSC after admission to the MW
4. At least 24 h after birth in the MW, at least 30 min after SSC. The success of the newborn sucking will be assessed using the LATCH at the following 3 measurement times.

(1) At least 5 min after the initiation of SSC in the OR (2)At least 1 h after admission to the MW, during SSC (3)At least 24 h after birth in the MW during SSC.

Intervention Type OTHER

SSC Group 2 (Post-operation room)

SC sampling from mothers, pain assessment (VAS), and measurement of physiological findings will be done at the following 3 measurement times. (1)Before transfer to the OR (2)1 hour (h) after admission to the PR (3)At least 1 h after admission to the MW.

The stress levels of newborns will be assessed using the "Neonatal Stress Scale" at the following 4 measurement times, and heart rate and oxygen saturation will be measured and recorded.

(1)At least 5 min after birth under radiant heater in the baby care room (BCR) (2)At least 10 min after being taken to the BCR during Hep-B vaccination under radiant heater (3)At least 5 min after being admitted to the maternity ward after SSC (4)5 min after being held in the mother's arms Newborn sucking success will be assessed using LATCH at the following 3 measurement times.

(1)At least 5 min after starting SSC in the post-op care unit (2)During SSC after being admitted to the MW (3)At least 24 h after being held in the mother's arms in the MW.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SSC1 SSC2

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Mothers;

* Planning a cesarean section with spinal anesthesia
* Being between the ages of 18-45
* Having a singleton pregnancy
* Being between the gestational age of 37-40 weeks
* Not having any known health problems (diabetes, gestational diabetes, hypertension, preeclampsia, renal failure, cardiac problems, psychiatric disorders, etc.)
* Agreeing to participate in the study
* Having stable general conditions and vital signs before the skin-to-skin contact procedure
* Residing in Kütahya

Newborns (0-28 days)

* Having a gestational age between 37-40 weeks
* Having a birth weight between 2500-4500 grams
* 1-5. Apgar score ≥ 7 per minute
* No health problems, anomalies or congenital diseases
* No conditions that prevent sucking such as frenulum (tongue tie) or palate problems

Exclusion Criteria

* Caesarean births performed with general anesthesia
* Normal births
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kutahya Health Sciences University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kütahya Health Sciences University

Merkez, Kütahya, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Betül Yavuz, PhD

Role: CONTACT

+90 274 260 00 43

Meltem Çatalbaş, PhD

Role: CONTACT

+90 274 260 00 43

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Betül Yavuz

Role: primary

05063160845

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Nursing 12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.